RxDoctor Payments Data

Phuong Nguyen, MD

Colon & Rectal Surgery · Redmond, ORNPI 1285782987

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,692 of the $6,923 with a category attached, or 82.2%. 13 manufacturers reported payments, led by Davol Inc. at 37.8% of the total. Reporting peaked in 2022 at $1,748 and has fallen 86.3% since, to $239 in 2025.

$6,923in general payments, 2019–2025

Across 92 payments — averaging $75.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Davol Inc.$3K
  • Intuitive Surgical$2K
  • Johnson & Johnson$1K
  • Stryker$546
  • Medtronic$276
  • Conmed Corporation$226
  • plus $205 from 7 others

What the payments were for

  • Speaking & faculty fees$1,22518%
  • Travel & lodging$60%
  • Food & beverage$5,69282%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,923 in reported general payments places this provider in the 60th percentile of 25 colon & rectal surgery providers in Oregon.

See all colon & rectal surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$126,097
Medicare patients
382
Services billed
660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates230$14,959
ClenpiqSod Picosulf/Mag Ox/Citric Ac34$5,804
SuprepSodium, Potassium,mag Sulfates55$4,506
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl42$637
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl43$563
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl23$447
Ondansetron Hcl375$313
Neomycin Sulfate21$85
Metronidazole19$20

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Redmond

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →